Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer

This important book provides up-to-date information on a series of topical issues relating to the approach to minimal residual disease in breast cancer patients. It first explains how the study of minimal residual disease and circulating and disseminated tumor cells (CTCs/DTCs) can assist in the understanding of breast cancer metastasis. A series of chapters then discuss the various technologies available for the detection and characterization of CTCs and DTCs, pinpointing their merits and limitations. Detailed consideration is given to the relevance of CTCs and DTCs, and their detection, to clinical research and practice. The role of other blood-based biomarkers is also addressed, and the closing chapters debate the challenges facing drug and biomarker co-development and the use of CTCs for companion diagnostic development. This book will be of interest and assistance to all who are engaged in the modern management of breast cancer.\nAdditional ISBNs\n9783642445873Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer 1st Edition is written by Michail Ignatiadis; Christos Sotiriou; Klaus Pantel and published by Springer. ISBNs for Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer are 9783642281600, 3642281605 and the print ISBNs are 9783642281594, 3642281591. Additional ISBNs include 9783642445873.